[1] [1] NDUMELE C E, RANGASWAMI J, CHOW S L, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association[J]. Circulation, 2023, 148(20): 1606-1635.

[2] [2] AGGARWAL R, OSTROMINSKI J W, VADUGANATHAN M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020[J]. JAMA, 2024, 331(21): 1858-1860.

[3] [3] KHAN S S, CORESH J, PENCINA M J, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association[J]. Circulation, 2023, 148(24): 1982-2004.

[4] [4] American Heart Association. Waist size predicts heart attacks better than BMI, especially in women[EB/OL]. [2025-02-01]. https://www.heart.org/en/news/2019/03/19/waist-size-predicts-heart-attacks-better-than-bmi-especially-in-women.

[5] [5] QIAO Y N, WANG Y, CHEN C, et al. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank[J]. Cardiovasc Diabetol, 2025, 24(1): 12.

[6] [6] CHEN T, LIU Y, WU S Q, et al. Comparison of TyG and newly TyG related indicators for chronic kidney diseases estimation in a Chinese population[J]. Diabetes Metab Syndr Obes, 2024, 17: 3063-3075.

[7] [7] REN Q S, HUANG Y, LIU Q, et al. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study[J]. Cardiovasc Diabetol, 2024, 23(1): 247.

[8] [8] HUANG Q, LI Y F, ZHOU X H, et al. Prevalence of the cardiovascular-kidney-metabolic syndrome in 3 Chinese cohorts[J]. JACC Asia, 2025, 5(1): 116-118.

[9] [9] LI N, LI Y Q, CUI L F, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality[J]. Atherosclerosis, 2024, 397: 118585.

[10] [10] LIU L J, SUN H, YI L, et al. Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study[J]. BMC Cardiovasc Disord, 2024, 24(1): 723.

[11] [11] PEI H, SU X, WU S L, et al. Evaluating the impact of chronic kidney disease and the triglyceride-glucose index on cardiovascular disease: mediation analysis in the NHANES[J]. BMC Public Health, 2024, 24(1): 2750.

[12] [12] MA Y L, JIN C H, ZHAO C C, et al. Waist-to-height ratio is a simple and practical alternative to waist circumference to diagnose metabolic syndrome in type 2 diabetes[J]. Front Nutr, 2022, 9: 986090.

[13] [13] WAKABAYASHI I. Necessity of both waist circumference and waist-to-height ratio for better evaluation of central obesity[J]. Metab Syndr Relat Disord, 2013, 11(3): 189-194.

[14] [14] KUNUTSOR S K, SEIDU S, KURL S, et al. Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study[J]. Geroscience, 2024, 46(3): 3035-3046.

[15] [15] WANG S L, ZHANG X H, MULATI B, et al. Prospective cohort study of the association of cardiovascular disease with triglyceride glucose index and triglyceride glucose-related indicators[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2023, 44(12): 1943-1949.